Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro

Journal of Virological Methods

Volumn 74, Issue 1, 1998, Pages 57-66

  Rimmelzwaan, G F ^a   Baars, M ^a   Claas, E C J ^a   Osterhaus, A D M E ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Influenza virus replication; MDCK cells; RNA hybridization

Indexed keywords

ANIMAL CELL; ARTICLE; HEMAGGLUTINATION TEST; INFLUENZA VIRUS; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; RNA HYBRIDIZATION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; CELL LINE; DOGS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HEMAGGLUTINATION TESTS; HUMANS; INFLUENZA A VIRUS; NUCLEIC ACID HYBRIDIZATION; RNA, VIRAL; TITRIMETRY; VIRUS REPLICATION;

EID: 0031866073     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(98)00071-8     Document Type: Article

References (9)

1. Duhaut, S.D., Maccauley, J.W., 1996. Defective RNAs inhibit the assembly of influenza virus genome segments in a segment-specific manner. Virology 216, 326-337.
2. Hayden, F.G., Osterhaus, A.D.M.E., Treanor, J.J., Fleming, D.M., Aoki, F.Y., Nickolson, K.G., Bohnen, A.M., Hirst, H.M., Keene, O., Wightman, K., 1997. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of the influenzavirus infections. New Engl. J. Med. 337, 874-880.
3. Karber, G., 1931. Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Exp. Pathol. Pharmakol. 162, 480-483.
4. Masurel, N., Ophof, P., De Jong, P., 1981. Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus. J. Hyg. 87, 201-209.
5. Rimmelzwaan, G.F., Baars, M., Van Beek, R., Van Amerongen, G., Lövgren-Bengtsson, K., Claas, E.C.J., Osterhaus, A.D.M.E., 1997. Induction of protective immunity against influenza in a macaque model: comparison of conventional and iscom vaccines. J. Gen. Virol. 78, 757-765.
6. Shapiro, G.I., Krug, R.M., 1988. Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer. J. Virol. 62, 2285-2290.
7. Shapiro, G.I., Gurney, T. Jr., Krug, R.M., 1987. Influenza virus gene expression: control mechanisms a early and late times of infection and nuclear-cytoplasmic transport of virus specific RNAs. J. Virol. 61, 764-773.
8. Smith, G.L., Hay, A.J., 1982. Replication of the influenza virus genome. Virology 118, 96-108.
9. Von Itzstein, M., Wu, W.Y., Kok, G.B., Pegg, M.S., Dyason, J.C., Jin, B., Van Phan, T., Smythe, M.L., White, H.F., Oliver, S.W., Colman, P.M., Varghese, J.N., Ryan, D.M., Woods, J.M., Bethell, R.C., Hotham, V.J., Cameron, J.M., Penn, C.R., 1993. Rational design of potential sialidase based inhibitors of influenza virus replication. Nature 363, 418-423.